211 related articles for article (PubMed ID: 23952890)
21. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
22. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
23. Treatment of nicotine dependence with Chantix (varenicline).
Rankin KV; Jones DL
Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacological profile and clinical findings on varenicline tartrate (Champix tablets)].
Hizue M; Ishibashi T; Nomura S
Nihon Yakurigaku Zasshi; 2010 May; 135(5):194-203. PubMed ID: 20467169
[No Abstract] [Full Text] [Related]
25. Nicotine dependence and smoking cessation.
Tan L; Tang Q; Hao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1049-57. PubMed ID: 19952392
[TBL] [Abstract][Full Text] [Related]
26. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
27. Varenicline for smoking cessation.
Tonstad S
Expert Rev Neurother; 2007 Feb; 7(2):121-7. PubMed ID: 17286546
[TBL] [Abstract][Full Text] [Related]
28. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
[TBL] [Abstract][Full Text] [Related]
29. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
Kamens HM; Andersen J; Picciotto MR
Psychopharmacology (Berl); 2010 Mar; 208(4):613-26. PubMed ID: 20072781
[TBL] [Abstract][Full Text] [Related]
30. Nicotinic receptor antagonists as treatments for nicotine abuse.
Crooks PA; Bardo MT; Dwoskin LP
Adv Pharmacol; 2014; 69():513-51. PubMed ID: 24484986
[TBL] [Abstract][Full Text] [Related]
31. Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Umene-Nakano W; Yoshimura R; Yoshii C; Hoshuyama T; Hayashi K; Hori H; Katsuki A; Ikenouchi-Sugita A; Nakamura J
Hum Psychopharmacol; 2010 Apr; 25(3):276-9. PubMed ID: 20373480
[TBL] [Abstract][Full Text] [Related]
32. Varenicline in stopping long-term nicotine use.
Berlin I
Am J Addict; 2012; 21(2):182-3. PubMed ID: 22332865
[No Abstract] [Full Text] [Related]
33. Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.
Ebbert JO; Wyatt KD; Zirakzadeh A; Burke MV; Hays J
Int J Chron Obstruct Pulmon Dis; 2009; 4():421-30. PubMed ID: 20037681
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Benowitz NL
Annu Rev Pharmacol Toxicol; 2009; 49():57-71. PubMed ID: 18834313
[TBL] [Abstract][Full Text] [Related]
35. Nicotine gum dependence treated with varenicline--a case report.
Garelik DA
Nicotine Tob Res; 2010 Oct; 12(10):1041-2. PubMed ID: 20829327
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study.
Boudrez H; Gratziou C; Messig M; Metcalfe M
Curr Med Res Opin; 2011 Apr; 27(4):769-75. PubMed ID: 21294601
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacotherapies for nicotine dependence: review of scientific evidence. Spanish Society of Smoking Specialists: recommendations about election and individualization].
Olano Espinosa E; Minué Lorenzo C; Ayesta Ayesta FJ;
Med Clin (Barc); 2011 Jan; 136(2):79-83. PubMed ID: 20884035
[No Abstract] [Full Text] [Related]
38. Reduced affective symptoms during tobacco dependence treatment with varenicline.
Grosshans M; Mutschler J; Hermann D; Mann K; Diehl A
Addiction; 2009 May; 104(5):859-61. PubMed ID: 19413797
[TBL] [Abstract][Full Text] [Related]
39. Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.
Hendrickson LM; Zhao-Shea R; Pang X; Gardner PD; Tapper AR
J Neurosci; 2010 Jul; 30(30):10169-76. PubMed ID: 20668200
[TBL] [Abstract][Full Text] [Related]
40. Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
Tutka P
Expert Opin Investig Drugs; 2008 Oct; 17(10):1473-85. PubMed ID: 18808308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
